68.98
price up icon0.57%   0.26
 
loading
Schlusskurs vom Vortag:
$68.72
Offen:
$68.6
24-Stunden-Volumen:
44,177
Relative Volume:
0.05
Marktkapitalisierung:
$10.92B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
45.38
EPS:
1.52
Netto-Cashflow:
$245.03M
1W Leistung:
-4.73%
1M Leistung:
-1.78%
6M Leistung:
-16.41%
1J Leistung:
+8.80%
1-Tages-Spanne:
Value
$68.42
$69.16
1-Wochen-Bereich:
Value
$65.61
$72.47
52-Wochen-Spanne:
Value
$61.16
$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name
Firmenname
Bio Techne Corp
Name
Telefon
(612) 379-8854
Name
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Mitarbeiter
3,100
Name
Twitter
@biotechne
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
TECH's Discussions on Twitter

Vergleichen Sie TECH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
TECH 69.04 10.92B 1.17B 150.71M 245.03M 1.52
VRTX 446.63 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.99 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.16 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.33 24.49B 3.30B -501.07M 1.03B 11.54

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-22 Herabstufung Citigroup Buy → Neutral
2024-02-08 Eingeleitet Scotiabank Sector Outperform
2024-02-02 Herabstufung Stifel Buy → Hold
2023-12-07 Eingeleitet UBS Buy
2023-08-28 Eingeleitet William Blair Outperform
2023-01-10 Hochstufung Wells Fargo Underweight → Equal Weight
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-12-12 Hochstufung Citigroup Neutral → Buy
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Herabstufung Wells Fargo Equal Weight → Underweight
2021-09-15 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 Hochstufung Stephens Equal-Weight → Overweight
2021-02-23 Hochstufung Stifel Hold → Buy
2021-01-25 Bestätigt The Benchmark Company Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-09-30 Eingeleitet Atlantic Equities Overweight
2020-07-15 Herabstufung Stephens Overweight → Equal-Weight
2020-05-27 Herabstufung Stifel Buy → Hold
2020-05-14 Eingeleitet The Benchmark Company Buy
2020-01-08 Fortgesetzt Stephens Overweight
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-11-15 Eingeleitet Stifel Buy
2019-07-02 Hochstufung Janney Neutral → Buy
2019-01-14 Hochstufung Stephens Equal-Weight → Overweight
2018-10-31 Herabstufung Craig Hallum Buy → Hold
2018-10-17 Eingeleitet Goldman Neutral
2018-06-15 Eingeleitet Argus Buy
2017-07-13 Eingeleitet Wells Fargo Market Perform
2017-02-09 Eingeleitet Citigroup Buy
2017-01-18 Eingeleitet Deutsche Bank Buy
2016-11-10 Fortgesetzt Leerink Partners Outperform
2015-01-21 Bestätigt Robert W. Baird Outperform
2013-09-20 Hochstufung Robert W. Baird Neutral → Outperform
Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

pulisher
04:12 AM

Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Natixis Advisors LLC - MarketBeat

04:12 AM
pulisher
04:12 AM

Thrivent Financial for Lutherans Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

04:12 AM
pulisher
Nov 20, 2024

Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Bio-Techne To Present At Stephens NASH 2024 Conference; Webcast At 12:00 PM ET - Nasdaq

Nov 20, 2024
pulisher
Nov 20, 2024

Bio-Techne partners with Leader Life Sciences in GCC - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Segall Bryant & Hamill LLC Has $38.20 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES - Yahoo Finance

Nov 20, 2024
pulisher
Nov 18, 2024

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH - Quantisnow

Nov 18, 2024
pulisher
Nov 17, 2024

Broadcrest Asset Management LLC Has $15.99 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 17, 2024
pulisher
Nov 15, 2024

Royce & Associates LP Acquires 17,296 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO - Quantisnow

Nov 14, 2024
pulisher
Nov 13, 2024

Geneva Capital Management LLC Has $88.27 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Bio-Techne To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET - Nasdaq

Nov 12, 2024
pulisher
Nov 12, 2024

Bio-Techne (NASDAQ:TECH) Raised to Buy at StockNews.com - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow

Nov 11, 2024
pulisher
Nov 11, 2024

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow

Nov 11, 2024
pulisher
Nov 10, 2024

Bio-Techne Co. (NASDAQ:TECH) is Montanaro Asset Management Ltd's 3rd Largest Position - MarketBeat

Nov 10, 2024
pulisher
Nov 10, 2024

Ownership Capital B.V. Sells 208,493 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 10, 2024
pulisher
Nov 10, 2024

When the Price of (TECH) Talks, People Listen - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 08, 2024

Bio-Techne Corporation: An Insight Into Its Market Position & Product Expansion in Diagnostics and Spatial Biology!Major Drivers - Smartkarma

Nov 08, 2024
pulisher
Nov 08, 2024

Asset Management One Co. Ltd. Has $9.69 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy - Quantisnow

Nov 07, 2024
pulisher
Nov 07, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Van ECK Associates Corp - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Ex-Dividend Reminder: Bio-Techne, Pfizer and Tompkins Financial - Nasdaq

Nov 06, 2024
pulisher
Nov 06, 2024

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING - WV News

Nov 06, 2024
pulisher
Nov 06, 2024

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Bio-Techne (FRA:TE1) Change In Receivables : €-33 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Bio-Techne Corporation (TECH) Announces Executive Compensation U - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Bio-Techne awards CFO restricted stock units for retention - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

TECH (Bio-Techne) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH - Quantisnow

Nov 05, 2024
pulisher
Nov 05, 2024

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Bio-Techne Corp (TECH)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus.com

Nov 04, 2024
pulisher
Nov 03, 2024

New York State Common Retirement Fund Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Bio-Techne (NASDAQ:TECH) Upgraded to Buy at StockNews.com - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

9 Best Biotech Stocks Of November 2024 - Forbes

Nov 01, 2024
pulisher
Nov 01, 2024

Bio-Techne Corporation (NASDAQ:TECH) Q1 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Oct 31, 2024

TECH (Bio-Techne) Total Inventories : $185 Mil (As of Sep. 2024) - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne Tops Profit Forecasts Thanks To Booming Diagnostics - Finimize

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne shares target raised, outperform on strong Q1 results By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Bio-Techne reports steady growth in Q1 FY2025 - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Bio-Techne reports steady growth in Q1 FY2025 By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne shares target raised, outperform on strong Q1 results - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Robert W. Baird Forecasts Strong Price Appreciation for Bio-Techne (NASDAQ:TECH) Stock - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigat - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Bio-Techne holds at $80 target with Overweight rating - Investing.com India

Oct 30, 2024

Finanzdaten der Bio Techne Corp-Aktie (TECH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bio Techne Corp-Aktie (TECH) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Hippel James
CFO
Nov 01 '24
Option Exercise
0.00
13,159
0
113,085
HIGGINS JOHN L
Director
Sep 12 '24
Option Exercise
22.95
6,000
137,700
48,608
Kelderman Kim
Chief Executive Officer
Aug 29 '24
Option Exercise
66.97
1,492
99,919
41,434
Bohnen Shane
SVP - General Counsel
Aug 15 '24
Option Exercise
0.00
49
0
1,696
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Option Exercise
22.95
16,000
367,200
59,401
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Sale
72.10
16,000
1,153,664
43,401
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):